|
|
Post by mnkdinvest on Dec 27, 2015 13:45:40 GMT -5
I have been a MNKD Investor since 2013. I am a IT professional. I strongly believe disruptive technology can improve live quality and it is pleasure to be part of the journey. In terms of the recent development of MNKD, I have a question, hope someone can shed some light on it:
why cash position and burning rate became such a big concern after FDA Approved Afrezza with partnership with SNY. If manifacture of Afrezza is the main source of the cash burn, isn't a easy job to slow down the production line to reduce cash burn? If SNY is paying further study of Afrezza, isn't the expense of R&D slow down? Should investor concerned about cash position more before FDA approval instead of now? We all know there is a game going on, just hope we can see a bit clearer of the game.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 27, 2015 14:14:38 GMT -5
all newbies register with MNKD in their screen name? You all belong to same pen?
|
|
|
|
Post by purge on Dec 27, 2015 14:20:43 GMT -5
I must admit. It is getting old.
|
|
|
|
Post by mnkdinvest on Dec 27, 2015 14:22:07 GMT -5
I am long and plan to add more . As I said I am an IT guy, my way of thinking is very straightforward , Afrezza is a great product and can change the world. Just want to get opinion from other people with different background for example finance or economy. How the crook in Wall Street can make this happened?
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 27, 2015 15:37:17 GMT -5
I am long and plan to add more . As I said I am an IT guy, my way of thinking is very straightforward , Afrezza is a great product and can change the world. Just want to get opinion from other people with different background for example finance or economy. How the crook in Wall Street can make this happened? can make this happened? are you from south asia if i may ask.. no offense just curious |
|
|
|
Post by suebeeee1 on Dec 27, 2015 15:47:27 GMT -5
I am editing this post because, frankly, it was just mean. I guess all of the "new" posters on this site have gotten to me lately. For some reason, I get the feeling we have seen them all, with different names in the past.  |
|
|
|
Post by mnkdmorelong on Dec 27, 2015 16:18:27 GMT -5
It is not the variable cost of production that is the problem. The Danbury facility is very large. They gave us a tour at the last Shareholders meeting in May and the problem was obvious. The production line is run in batch mode since demand is so low. Since then, MNKD has added two more filling lines that are not needed now. To support the marketing of Technosphere as an excipient, a large technical staff is needed. And of course there are the bonds that need to be serviced.
MNKD just had another round of layoffs which will help the cash burn rate. Not good enough; more cash is needed to tide the company through until Afrezza sales throw off cash.
You are into disruptive technology with Afrezza. It will one day be the every day prandial insulin for T1s. The key question is, will the current capital structure survive until that date.
|
|
|
|
Post by tmann on Dec 27, 2015 16:40:44 GMT -5
Sounds bad.
Maybe you should take a short position?
|
|
|
|
Post by suebeeee1 on Dec 27, 2015 16:47:05 GMT -5
|
|
|
|
Post by mnkdnewb on Dec 27, 2015 18:38:18 GMT -5
I was thinking the same thing. Makes me want to change my user name! |
|
